Integra Lifesciences (NASDAQ: IART) reported Q2 EPS of $0.68, $0.04 better than the analyst estimate of $0.64. Revenue for the quarter came in at $231.4 million versus the consensus estimate of $229.32 million.

For earnings history and earnings-related data on Integra Lifesciences (IART) click here.